Latest News

  • Silicon Therapeutics Unveils Refreshed Corporate Branding and Redesigned Website

    BOSTON, OCT. 6, 2020 — Silicon Therapeutics, a privately-held, fully integrated drug design, discovery and development company focused on small molecule therapeutics, today introduced an updated corporate website, which reflects the company’s mission, research approach and core values. The new Silicon Therapeutics site more accurately tells the company’s story and clearly highlights the company’s mission to improve the lives of patients

  • Silicon Therapeutics Appoints Pamela Carroll, Ph.D. as Chief Business Officer

    BOSTON — (BUSINESS WIRE) — Silicon Therapeutics (SiTX) announced today that Pamela Carroll, Ph.D. has been appointed Chief Business Officer to lead corporate strategy and business development. Dr. Carroll joins Silicon Therapeutics after more than 20 years in senior research and leadership positions at Johnson & Johnson, Roche, the Dana Farber Cancer Institute, and most recently at

  • Silicon Therapeutics Expands Leadership Team with Key Appointments in Clinical Development and Strategy as well as Computational Physics

    BOSTON–(BUSINESS WIRE)–Silicon Therapeutics today announced three additions to its management team to help lead the company through its next stage of growth. Humphrey Gardner, MD, FCAP has joined the company as Chief Medical Officer; Christopher Borella, PhD, has joined as Vice President, Head of Operations; and Huafeng Xu, PhD, has joined as Chief Technology Officer.

All Press Releases